• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    US Healthcare Ishares ETF (NY: IYH )

    60.90 +0.04 (+0.07%)
    Official Closing Price Updated: 8:00 PM EDT, Jun 18, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 266,371
    Open 60.85
    Bid (Size) 60.72 (4)
    Ask (Size) 61.99 (24)
    Prev. Close 60.86
    Today's Range 60.76 - 61.08
    52wk Range 57.95 - 310.69
    Shares Outstanding 543,000
    Dividend Yield 7.68%
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    'Barbarism:' AOC Unleashes Fury On US Healthcare System As People Are 'Choosing Between Medicine And Rent'
    America has one of the highest healthcare costs in the world, with healthcare spending hitting $4.5 trillion in 2022. 
    Via Benzinga
    ETFs To Buy As Eli Lilly Beats Q1 Earnings, Lifts Outlook
    Eli Lilly and Company posted mixed first-quarter 2024 earnings, beating earnings estimates but lagging on revenues. Investors seeking to tap the opportune moment could bet on ETFs having the largest... 
    Via Talk Markets
    Topics ETFs

    Performance

    YTD
    -79.05%
    -79.05%
    1 Month
    -0.56%
    -0.56%
    3 Month
    -0.62%
    -0.62%
    6 Month
    -78.52%
    -78.52%
    1 Year
    -78.10%
    -78.10%

    More News

    Read More
    Target, Apollo Global Management, Las Vegas Sands And More: CNBC's 'Final Trades'
    Via Benzinga
    Upward Trajectory For Biotech/Pharma M&A: Sector Trends Towards Pre-Pandemic Levels, Forecasts Positive For 2024
    Via Benzinga
    Pfizer's Dividend Yield Is 5.7%, Plus Humana And Shake Shack On CNBC's 'Final Trades'
    Via Benzinga
    Cigna Drops Humana Merger, Opts For $10 Billion Buyback Strategy
    Via Benzinga
    Humana, Comerica, Cleveland-Cliffs, And More: CNBC's 'Final Trades'
    Via Benzinga
    Cisco, Burlington Stores, Broadcom And More On CNBC's 'Final Trades'
    Via Benzinga
    Lab-Developed Tests Under FDA Scrutiny: What It Means For Startups
    Via Benzinga
    Exposures Product Safety
    All eyes on the Fed as inflation metrics give mixed signals
    Via Talk Markets
    Topics Economy
    Exposures Interest Rates
    Beyond The Hustle: Embracing Ancient Chinese Wisdom To Combat Modern Day Burnout
    Via Benzinga
    4 Top-Ranked Sector ETFs To Buy In The Second Half
    Via Talk Markets
    From AI to Obesity Drugs - Global Pharma Has $700B For M&A and Investments: Goldman Sachs
    Via Benzinga
    The 3 Most Promising Industries to Invest in for 2023’s Second Half
    Via InvestorPlace
    Stocks Flounder Despite Inflation Downtrend As Banking Crisis Emerges, But Outlook Remains Encouraging
    Via Talk Markets
    Got $10,000? Buy These 2 Market-Beating ETFs for the Long Haul
    Via The Motley Fool
    Uncertainties On Fed Policy, Geopolitics, And Earnings Cloud 2023 Outlook, But Trends Are Promising
    Via Talk Markets
    Worried About 2023? Here's a Safer Way to Invest in Stocks This Year
    Via The Motley Fool
    The 3 Best Sectors to Invest in for 2023
    Via InvestorPlace
    Health Care Exposure Ahead Of CPI Data, Progressive, Dollar General And Seagate Technology Feature On CNBC's 'Final Trades'
    Via Benzinga
    Investors Await Bullish Catalysts As Inflation, Interest Rates, And Money Supply Growth Show Signs Of Topping
    Via Talk Markets
    CNBC's Final Trades: Microsoft, US Dollar Index, iShares Healthcare ETF And This Cybersecurity Tech Major
    Via Benzinga
    Adobe Earnings Strangle Trade
    Via Talk Markets
    Why WHO Did Not Recommend Convalescent Plasma Therapy For COVID-19
    Via Benzinga
    Exposures COVID-19
    New Drug Applications Pile Up With FDA As Pandemic Still Sore Spot For Delayed Inspections
    Via Benzinga
    Exposures Product Safety
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.